Resveratrol inhibits diabetes-related cardiac dysfunction and hypertrophy in multiple low doses of streptozotocin-induced diabetic mice by restoring NRF2 and its downstream antioxidative genes, such as SOD, heme oxygenase-1 (HO-1), and metallothionein (MT) [63]. The gene discussed is NFE2L2; the disease is diabetes mellitus.